References

  1. Watson-Jones D, Weiss HA, Rusizoka M, Changalucha J, Baisley K, Mugeye K, Tanton C, Ross D, Everett D, Clayton T, Balira R, Knight L, Hambleton I, LeGoff J, Belec L, Hayes R: Effect of herpes simplex suppression on incidence of HIV among women in Tanzania.

    N Engl J Med 2008 , 358:1560-1571. PubMed Abstract | Publisher Full Text OpenURL

  2. Celum C, Wald A, Hughes J, Sanchez J, Reid S, Delany-Moretlwe S, Cowan F, Casapia M, Oritz A, Fuchs J, Buchbinder S, Koblin B, Zwerski S, Rose S, Wang J, Corey L: Twice Daily Acyclovir Does Not Reduce the Risk of HIV-1 Acquisition among HSV-2 Seropositive Women and Men who have sex with Men (MSM).

    Lancet 2008 , 371:2109-2191. PubMed Abstract | Publisher Full Text OpenURL

  3. Padian NS, Straten A, Ramjee G, Chipato T, de Bruyn G, Blanchard K, Shiboski S, Montgomery ET, Fancher H, Cheng H, Rosenblum M, Laan M, Jewell N, McIntyre J: Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial.

    Lancet 2007 , 370:251-261. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  4. Robertson M, Mehrotra D, Fitzgerald D, Duerr A, Casimiro J, McElrath J, Lawrence D, Buchbinder S: Efficacy Results from the STEP Study (Merck V520 Protocol 023/HVTN 502): A Phase II Test-of-Concept Trial of the MRKAd5 HIV-1 Gag/Pol/Nef Trivalent Vaccine.

    CROI; February 3–6, 2008; Boston 2008. OpenURL

  5. Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, Nalugoda F, Kiwanuka N, Moulton LH, Chaudhary MA, Chen MZ, Sewankambo N, Wabwire-Mangen F, Bacon MC, Williams CF, Opendi P, Reynolds SJ, Laeyendecker O, Quinn TC, Wawer MJ: Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial.

    Lancet 2007 , 369:657-666. PubMed Abstract | Publisher Full Text OpenURL

  6. Bailey RC, Moses S, Parker CB, Agot K, Maclean I, Krieger JN, Williams CF, Campbell RT, Ndinya-Achola JO: Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial.

    Lancet 2007 , 369:643-656. PubMed Abstract | Publisher Full Text OpenURL

  7. Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A: Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial.

    PLoS Med 2005 , 2:e298. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  8. Grosskurth H, Mosha F, Todd J, Mwijarubi E, Klokke A, Senkoro K, Mayaud P, Changalucha J, Nicoll A, ka-Gina G, Newell J, Mugeye K, Mabey D, Hayes RJ: Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial.

    Lancet 1995 , 346:530-536. PubMed Abstract | Publisher Full Text OpenURL

  9. Hayes RJ, Schulz KF, Plummer FA: The cofactor effect of genital ulcers on the per-exposure risk of HIV transmission in sub-Saharan Africa.

    J Trop Med Hyg 1995 , 98:1-8. PubMed Abstract OpenURL

  10. Rottingen JA, Garnett GP: The epidemiological and control implications of HIV transmission probabilities within partnerships.

    Sex Transm Dis 2002 , 29:818-827. PubMed Abstract | Publisher Full Text OpenURL

  11. Wawer MJ, Gray RH, Sewankambo NK, Serwadda D, Li X, Laeyendecker O, Kiwanuka N, Kigozi G, Kiddugavu M, Lutalo T, Nalugoda F, Wabwire-Mangen F, Meehan MP, Quinn TC: Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda.

    J Infect Dis 2005 , 191:1403-1409. PubMed Abstract | Publisher Full Text OpenURL

  12. Vittinghoff E, Douglas J, Judson F, McKirnan D, MacQueen K, Buchbinder SP: Per-contact risk of human immunodeficiency virus transmission between male sexual partners.

    Am J Epidemiol 1999 , 150:306-311. PubMed Abstract | Publisher Full Text OpenURL

  13. Weiss HA, Quigley MA, Hayes RJ: Male circumcision and risk of HIV infection in sub-Saharan Africa: a systematic review and meta-analysis.

    Aids 2000 , 14:2361-2370. PubMed Abstract | Publisher Full Text OpenURL

  14. Kaul R, Kimani J, Nagelkerke NJ, Fonck K, Ngugi EN, Keli F, MacDonald KS, Maclean IW, Bwayo JJ, Temmerman M, Ronald AR, Moses S: Monthly antibiotic chemoprophylaxis and incidence of sexually transmitted infections and HIV-1 infection in Kenyan sex workers: a randomized controlled trial.

    Jama 2004 , 291:2555-2562. PubMed Abstract | Publisher Full Text OpenURL

  15. Kamali A, Quigley M, Nakiyingi J, Kinsman J, Kengeya-Kayondo J, Gopal R, Ojwiya A, Hughes P, Carpenter LM, Whitworth J: Syndromic management of sexually-transmitted infections and behaviour change interventions on transmission of HIV-1 in rural Uganda: a community randomised trial.

    Lancet 2003 , 361:645-652. PubMed Abstract | Publisher Full Text OpenURL

  16. Wawer MJ, Sewankambo NK, Serwadda D, Quinn TC, Paxton LA, Kiwanuka N, Wabwire-Mangen F, Li C, Lutalo T, Nalugoda F, Gaydos CA, Moulton LH, Meehan MO, Ahmed S, Gray RH: Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Rakai Project Study Group.

    Lancet 1999 , 353:525-535. PubMed Abstract | Publisher Full Text OpenURL

  17. White RG, Orroth KK, Korenromp EL, Bakker R, Wambura M, Sewankambo NK, Gray RH, Kamali A, Whitworth JA, Grosskurth H, Habbema JD, Hayes RJ: Can population differences explain the contrasting results of the Mwanza, Rakai, and Masaka HIV/sexually transmitted disease intervention trials?: A modeling study.

    J Acquir Immune Defic Syndr 2004 , 37:1500-1513. PubMed Abstract | Publisher Full Text OpenURL

  18. Orroth KK, White RG, Korenromp EL, Bakker R, Changalucha J, Habbema JD, Hayes RJ: Empirical observations underestimate the proportion of human immunodeficiency virus infections attributable to sexually transmitted diseases in the Mwanza and Rakai sexually transmitted disease treatment trials: Simulation results.

    Sex Transm Dis 2006 , 33:536-544. PubMed Abstract | Publisher Full Text OpenURL

  19. Korenromp EL, White RG, Orroth KK, Bakker R, Kamali A, Serwadda D, Gray RH, Grosskurth H, Habbema JD, Hayes RJ: Determinants of the impact of sexually transmitted infection treatment on prevention of HIV infection: a synthesis of evidence from the Mwanza, Rakai, and Masaka intervention trials.

    J Infect Dis 2005 , 191(Suppl 1):S168-178. PubMed Abstract | Publisher Full Text OpenURL

  20. Grosskurth H, Gray R, Hayes R, Mabey D, Wawer M: Control of sexually transmitted diseases for HIV-1 prevention: understanding the implications of the Mwanza and Rakai trials.

    Lancet 2000 , 355:1981-1987. PubMed Abstract | Publisher Full Text OpenURL

  21. DHS: Zimbabwe 2005–2006 Demographic and Health Surveys.

  22. DHS: South Africa 1998 Demographic and Health Surveys.

  23. Mills EJ, Nachega JB, Buchan I, Orbinski J, Attaran A, Singh S, Rachlis B, Wu P, Cooper C, Thabane L, Wilson K, Guyatt GH, Bangsberg DR: Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis.

    JAMA 2006 , 296:679-690. PubMed Abstract | Publisher Full Text OpenURL

  24. Koblin B, Chesney M, Coates T: Effects of a behavioural intervention to reduce acquisition of HIV infection among men who have sex with men: the EXPLORE randomised controlled study.

    Lancet 2004 , 364:41-50. PubMed Abstract | Publisher Full Text OpenURL

  25. Corbett EL, Makamure B, Cheung YB, Dauya E, Matambo R, Bandason T, Munyati SS, Mason PR, Butterworth AE, Hayes RJ: HIV incidence during a cluster-randomized trial of two strategies providing voluntary counselling and testing at the workplace, Zimbabwe.

    Aids 2007 , 21:483-489. PubMed Abstract | Publisher Full Text OpenURL

  26. Pronyk PM, Hargreaves JR, Kim JC, Morison LA, Phetla G, Watts C, Busza J, Porter JD: Effect of a structural intervention for the prevention of intimate-partner violence and HIV in rural South Africa: a cluster randomised trial.

    Lancet 2006 , 368:1973-1983. PubMed Abstract | Publisher Full Text OpenURL

  27. Ross DA, Changalucha J, Obasi AI, Todd J, Plummer ML, Cleophas-Mazige B, Anemona A, Everett D, Weiss HA, Mabey DC, Grosskurth H, Hayes RJ: Biological and behavioural impact of an adolescent sexual health intervention in Tanzania: a community-randomized trial.

    AIDS 2007 , 21:1943-1955. PubMed Abstract | Publisher Full Text OpenURL

  28. NIMH Collaborative HIV/STD Prevention Trial Group: Methodological overview of a five-country community-level HIV/sexually transmitted disease prevention trial.

    AIDS 2007 , 21(Suppl 2):S3-18. PubMed Abstract | Publisher Full Text OpenURL

  29. NIMH Project Accept/HPTN 043 [http://www.cbvct.med.ucla.edu/overview.html#contact]

  30. The Regai Dzive Shiri Programme: 2002–2007 [http://spw.org/downloads/SPW_RDS_summary.pdf]

  31. Wawer MJ, Kigozi G, Serwadda D, Watya S, Makumbi F, Nalugoda F, Watya S, Buwembo D, Ssempija V, Moulton L, Gray R: Trial of male circumcision in HIV+ men: effects in men and women.

    15th Conference on Retroviruses and Opportunistic Infections. Boston 2008. OpenURL

  32. Feldblum PJ, Adeiga A, Bakare R, Wevill S, Lendvay A, Obadaki F, Olayemi MO, Wang L, Nanda K, Rountree W: SAVVY vaginal gel (C31G) for prevention of HIV infection: a randomized controlled trial in Nigeria.

    PLoS ONE 2008 , 3:e1474. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  33. Halpern V, Wang L, Obunge O, Ogunsola F, Mehta N, Onyejepu N, Oduyebo O, Taylor D, Otusanya S, Umo-Otong J, McNeil L, Bragg V, Cates W: Effectiveness of cellulose sulfate gel for prevention of HIV: results of the phase III trial in Nigeria.

    4th IAS Conference on HIV Pathogenesis, Treatment and Prevention 2007. OpenURL

  34. Kreiss J, Ngugi E, Holmes K, Ndinya-Achola J, Waiyaki P, Roberts PL, Ruminjo I, Sajabi R, Kimata J, Fleming TR: Efficacy of nonoxynol 9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes.

    JAMA 1992 , 268:477-482. PubMed Abstract | Publisher Full Text OpenURL

  35. Peterson L, Nanda K, Opoku BK, Ampofo WK, Owusu-Amoako M, Boakye AY, Rountree W, Troxler A, Dominik R, Roddy R, Dorflinger L: SAVVY (C31G) gel for prevention of HIV infection in women: a Phase 3, double-blind, randomized, placebo-controlled trial in Ghana.

    PLoS ONE 2007 , 2:e1312. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  36. Population Council: Trial Shows Anti-HIV Microbicide Is Safe, but Does Not Prove It Effective.

    Press Release. New York 2008. OpenURL

  37. Richardson BA, Lavreys L, Martin HL Jr, Stevens CE, Ngugi E, Mandaliya K, Bwayo J, Ndinya-Achola J, Kreiss JK: Evaluation of a low-dose nonoxynol-9 gel for the prevention of sexually transmitted diseases: a randomized clinical trial.

    Sex Transm Dis 2001 , 28:394-400. PubMed Abstract | Publisher Full Text OpenURL

  38. Roddy RE, Zekeng L, Ryan KA, Tamoufe U, Weir SS, Wong EL: A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases.

    N Engl J Med 1998 , 339:504-510. PubMed Abstract | Publisher Full Text OpenURL

  39. Van Damme L, Govinden R, Mirembe F, Guedou F, Solomon S, Becker ML, Pradeep B, Alary M, Nakabiito C, Ramjee G, Murphy S, Deese J, Crucitti T, Taylor D: Phase III trial of 6% cellulose sulfate (CS) gel for the prevention of HIV transmission.

    4th IAS Conference on HIV Pathogenesis, Treatment and Prevention. Sydney, Australia 2007. OpenURL

  40. Van Damme L, Ramjee G, Alary M, Vuylsteke B, Chandeying V, Rees H, Sirivongrangson P, Mukenge-Tshibaka L, Ettiegne-Traore V, Uaheowitchai C, Karim SS, Masse B, Perriens J, Laga M: Effectiveness of COL- a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial.

    Lancet 1492 , 360:971-977. Publisher Full Text OpenURL

  41. Phase II/IIb Safety and Effectiveness Study of the Vaginal Microbicides BufferGel and 0.5% PRO2000/5 Gel (P) for the Prevention of HIV Infection in Women [http://clinicaltrials.gov/ct/show/NCT00074425?order=1]

  42. Phase IIb Trial to Assess the Safety and Effectiveness of the Vaginal Microbicide 1% Tenofovir Gel for the Prevention of HIV Infection in Women in South Africa [http://clinicaltrials.gov/show/NCT00441298]

  43. Trial to Evaluate PRO 2000/5 Gels for the Prevention of Vaginally Acquired HIV Infection [http://clinicaltrials.gov/ct/show/NCT00262106?order=2]

  44. Bangkok Tenofovir Study [http://clinicaltrials.gov/ct2/show/NCT00119106?term=Thailand+CDC&rank=2]

  45. Botswana TDF/FTC Oral HIV Prophylaxis Trial [http://clinicaltrials.gov/ct2/show/NCT00448669?term=botswana&rank=1]

  46. Anti-HIV Medications for the Prevention of HIV Infection in Latin American Men Who Have Sex With Men [http:/ / clinicaltrials.gov/ ct/ show/ NCT00350324;jsessionid=C6AE509A400F D7C0031FC56FD42AE515?order=39]

  47. Pre-Exposure Prophylaxis to Prevent HIV-1 Acquisition Within HIV-1 Discordant Couples (PartnersPrEP) [http://clinicaltrials.gov/ct2/show/NCT00557245?intr=%22Placebo%22&rank=30]

  48. A Randomized Trial to Evaluate the Effectiveness of Antiretroviral Therapy Plus HIV Primary Care versus HIV Primary Care Alone to Prevent the Sexual Transmission of HIV-1 in Serodiscordant Couples [http://www.hptn.org/research_studies/hptn052.asp]

  49. Herpes Simplex Virus Type 2 (HSV-2) Suppression to Prevent HIV Transmission [http://clinicaltrials.gov/show/NCT00194519?order=32]

  50. Gregson S, Adamson S, Papaya S, Mundondo J, Nyamukapa CA, Mason PR, Garnett GP, Chandiwana SK, Foster G, Anderson RM: Impact and process evaluation of integrated community and clinic-based HIV-1 control: a cluster-randomised trial in eastern Zimbabwe.

    PLoS Med 2007 , 4:e102. PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL

  51. Flynn NM, Forthal DN, Harro CD, Judson FN, Mayer KH, Para MF: Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection.

    J Infect Dis 2005 , 191:654-665. PubMed Abstract | Publisher Full Text OpenURL

  52. Safety and Efficacy of a Three-Dose Regimen of an Adenoviral HIV Vaccine (MRKAd5 HIV-1 Gag/Pol/Nef) in HIV Uninfected South African Adults [http:/ / clinicaltrials.gov/ ct/ show/ NCT00413725;jsessionid=A6758E80AEA5 A1111E76F301C01DE11E?order=2]

  53. Pitisuttithum P, Gilbert P, Gurwith M, Heyward W, Martin M, van Griensven F, Hu D, Tappero JW, Choopanya K: Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand.

    J Infect Dis 2006 , 194:1661-1671. PubMed Abstract | Publisher Full Text OpenURL

  54. Rerks-Ngarm S, Brown AE, Khamboonruang C, Thongcharoen P, Kunasol P: HIV/AIDS preventive vaccine 'prime-boost' phase III trial: foundations and initial lessons learned from Thailand.

    Aids 2006 , 20:1471-1479. PubMed Abstract | Publisher Full Text OpenURL